PHARMACY

Teva gets FDA clearance for first EpiPen generics
Teva will market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths.
Sun Pharma gets FDA nod for Cequa's dry eye treatment
Sun Pharma’s Cequa (cyclosporine ophthalmic solution) 0.09% for topical ophthalmic use combines cyclosporine A with nanomicellar technology, the company said.

OptumRx unveils sustainable medication packaging

OptumRx is replacing polystyrene, or foam, packaging with 100% renewable cotton medication packaging that is recyclable for its home delivery patients.
Hikma adds generics sales, marketing EVP

Kristy Ronco will lead Hikma's generics’ retail sales, addiction therapy sales, and branded sales teams.
Geisinger and Merck unveil Medtrue and Family Caregiver apps

Geisinger and Merck's Medtrue and Family Caregiver apps can be accessed in healthcare systems and the patient's home.
Emergent BioSolutions to acquire PaxVax

Emergent BioSolutions' agreement to acquire PaxVax will bring several specialty vaccines for typhoid fever and cholera to the company's portfolio.
CVS Health addresses Ohio Medicaid pricing requirements

CVS Health issues a statement praising PBMs for saving Ohio taxpayers money, while noting that the company will continue to help Ohio Medicaid clients manage their drug costs.
Alembic gains FDA tentative approval for generic Latisse

Alembic gets tentative approval from the FDA for a generic version of Allergan's Latisse ophthalmic solution. The product has a market value of approximately $63 million.
Cipla introduces generic Xeloda

Cipla is launching the generic version of Genentech's Xeloda in two dosage strengths in partnership with MSN Laboratories
CVS Health survey: More consumers likely to get flu shot this season

Knowledge of last year's high flu levels is encouraging consumers to get vaccinated this season, according to a recent survey by CVS Health.